The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Biogen Idec Inc  (BIIB) Trade Now »     Rate BIIB  -  Discuss BIIB  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks
This Quarter's Sentiment:
All:
80.0%
Top:
66.5%
Rate BIIB:



BIIB Analysis & Videos »


BIIB: Bull or Bear?

FDA Calendar Updates: Amgen, Bayer, Biogen, Noveko, Peplin, Transdel Graphic_rating_buy BIIB
Mikerun
73%
+6.78%
in 152 days
By  Mike Havrilla   (+1.04%  risk: conservative)  07/08/09 Comment


FDA Decision Calendar: Pain Drug Delays Likely Graphic_rating_buy BIIB
Mikerun
73%
-12.22%
in 148 days
(closed on 07/08/09)
By  Mike Havrilla   (+1.04%  risk: conservative)  02/10/09 Comment


Drug and health care stocks: The right prescription for 2009 Graphic_rating_buy BIIB
+1.56%
in 336 days
By  Steven Halpern   (+5.50%  risk: moderate)  01/05/09 Comment


Get free stock alert for BIIB:
Your Email Address:


Biotech no longer a safe haven: Elan (ELN) falls on hard times Graphic_rating_sell BIIB
-3.39%
in 359 days
By  Jamie Dlugosch   (+43.97%  risk: conservative)  12/12/08 Comment


Biogen Reports Another PML Case in Tysabri Patient Graphic_rating_buy BIIB
Mikerun
73%
+29.15%
in 102 days
(closed on 02/10/09)
By  Mike Havrilla   (+1.04%  risk: conservative)  10/30/08 Comment


Biogen Reports Another PML Case in Tysabri Patient Graphic_rating_buy BIIB
Mikerun
73%
+0.00%
in 3 hours
(closed on 10/30/08)
By  Mike Havrilla   (+1.04%  risk: conservative)  10/29/08 Comment


Biotech Blues: Four Stocks on Sale with Hope Graphic_rating_buy BIIB
Mikerun
73%
-3.42%
in 4 days
(closed on 10/29/08)
By  Mike Havrilla   (+1.04%  risk: conservative)  10/25/08 Comment


Who's Next in the Biotech Buyout Frenzy? Graphic_rating_buy BIIB
Mikerun
73%
-6.30%
in 12 days
(closed on 10/25/08)
By  Mike Havrilla   (+1.04%  risk: conservative)  10/13/08 Comment


Get free stock alert for BIIB:
Your Email Address:


An Even Pfatter Yield at Pfizer Graphic_rating_buy BIIB
Mikerun
73%
+0.00%
in 1 hours
(closed on 10/13/08)
By  Mike Havrilla   (+1.04%  risk: conservative)  10/12/08 Comment


Clarity on Tysabri Makes Elan and Biogen a Buy Graphic_rating_buy BIIB
Rxlogo
50%
-0.84%
in 456 days
By  Mike Havrilla   (-9.11%  risk: conservative)  09/06/08 Comment


Clarity on Tysabri Makes Elan and Biogen a Buy Graphic_rating_buy BIIB
Mikerun
73%
-9.49%
in 35 days
(closed on 10/11/08)
By  Mike Havrilla   (+1.04%  risk: conservative)  09/06/08 Comment


Biogen-Idec, Elan: Panic Selling Creates Interesting Opportunity Graphic_rating_buy BIIB
-4.93%
in 482 days
By  A. Reza Saadat   (-26.39%  risk: conservative)  08/11/08 Comment


Still bullish on this guy. Graphic_rating_buy BIIB
Condor
41%
-31.17%
in 499 days
By  Doodahdoodoo   (-4.59%  risk: aggressive)  07/25/08 Comment


Cramer on BloggingStocks: Genentech bid confirms the trend Graphic_rating_buy BIIB
-27.93%
in 503 days
By  Jim Cramer   (+2.42%  risk: moderate)  07/21/08 Comment


Biogen Idec Inc Graphic_rating_buy BIIB
Foto
62%
-23.16%
in 515 days
By  Marian Filo   (-24.55%  risk: aggressive)  07/09/08 Comment





People Bullish on BIIB

sdepatie
Analyst
N/A
about 1 mo ago

Mikerun
Mike Havrilla
Principal
73%
5 mos ago

henmeng
Analyst
N/A
5 mos ago

phoebex
Analyst
N/A
6 mos ago

seismicstock
Principal
70%
7 mos ago


People Bearish on BIIB

Jamie Dlugosch
Tracked Blogger
78%
11 mos ago

webmom
Analyst
59%
about 1 year ago

mlgeorge
Analyst
N/A
about 1 year ago

Andrew C
Analyst
 6 %
about 1 year ago

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.44% 381
2 18.14 +68.27% 211
3 17.66 +25.61% 55
4 13.47 +14.32% 62
5 12.13 +74.42% 40


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on BIIB


Discussion Wall + Add  

amritadas   (+0.00%)
A FREE report on the approval of a new Gout Drug FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   0 replies

amritadas   (+0.00%)
Free report on upcoming FDA panel decision of Corvu.. FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   0 replies


More Resources

Graphic_arrow1 About Biogen Idec Inc - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch